Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.89%
1,083.04
-9.76
-0.89%
—1,092.801,093.681,094.851,081.97——
SIXC
Communications
SIXC
Communications
SIXC
-0.39%
602.38
-2.36
-0.39%
—604.74604.74605.10601.34——
SIXE
Energy
SIXE
Energy
SIXE
+2.31%
1,242.83
+28.03
+2.31%
—1,214.801,220.811,243.821,220.81——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.62%
1,713.82
-10.75
-0.62%
—1,724.571,727.021,732.301,707.43——
SIXM
Financials
SIXM
Financials
SIXM
+0.09%
639.99
+0.56
+0.09%
—639.43641.58644.53637.50——
SIXR
Staples
SIXR
Staples
SIXR
-0.20%
837.46
-1.69
-0.20%
—839.15836.90840.48832.89——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.65%
214.22
-1.40
-0.65%
—215.62215.62216.21213.48——
SIXT
Technology
SIXT
Technology
SIXT
+0.78%
3,204.38
+24.86
+0.78%
—3,179.523,191.503,205.093,177.75——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.23%
925.38
-11.53
-1.23%
—936.91935.42937.17923.20——
SIXV
Health care
SIXV
Health care
SIXV
-0.69%
1,442.71
-10.06
-0.69%
—1,452.771,445.931,447.431,434.91——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.16%
2,361.34
-3.84
-0.16%
—2,365.182,353.642,368.102,347.80——
SNW:ETR
Sanofi SA
€79.03
+1.02%
(+0.80) 1D
Apr 30, 2:51:42 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for SNW...
Open
€78.31
High
€79.35
Low
€78.00
Mkt. cap
96.03B
Avg. vol.
18.65K
Volume
11.94K
P/E ratio
12.78
52-wk high
€98.27
52-wk low
€74.92
EPS
€6.18
Shares outstanding
1.25B
No. of employees
75K
News stories
From sources across the web
Profile
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company’s seat in the Forbes Global 2000 was 89. Sanofi engages in the research and development, manufacturing, and marketing of pharmacological products, principally in the prescription market, but the firm also develops over-the-counter medications. The corporation covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis, and vaccines. It is the world's largest producer of vaccines through its subsidiary Sanofi Pasteur. Wikipedia
About Sanofi SA
CEOPaul Hudson
Employees74.8K
Founded1973
HeadquartersParis, Île-de-France, France
SectorPharmaceutical industry
Websitesanofi.com
Last report
Apr 23, 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
1.88/ (1.80 est.)EUR
+4.50%beat
Revenue / Estimate
11.24B/ (10.23B est.)EUR
+9.96%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
10.74B
13.17B
12.20B
11.24B
Cost of goods sold
2.99B
3.41B
3.63B
3.06B
Cost of revenue
2.99B
3.41B
3.63B
3.06B
Research and development expenses
1.91B
1.83B
2.29B
1.75B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.28B
2.29B
2.82B
2.33B
Operating expense
5.71B
5.97B
6.84B
5.94B
Total operating expenses
8.70B
9.39B
10.46B
9.00B
Operating income
2.04B
3.78B
1.74B
2.25B
Other non operating income
-
-
122.00M
-40.00M
EBT including unusual items
1.47B
3.51B
-1.16B
2.01B
EBT excluding unusual items
2.03B
3.67B
1.70B
2.14B
Income tax expense
230.00M
680.00M
-348.00M
420.00M
Effective tax rate
15.69%
19.38%
30.13%
20.85%
Other operating expenses
1.14B
1.39B
1.19B
1.33B
Net income
3.94B
2.80B
-801.00M
1.61B
Net profit margin
36.69%
21.28%
-6.56%
14.35%
Earnings per share
-
-
1.53
1.88
Interest and investment income
98.00M
114.00M
79.00M
60.00M
Interest expense
-148.00M
-227.00M
-
-138.00M
Net interest expenses
-50.00M
-113.00M
79.00M
-78.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.79B
4.20B
3.49B
2.78B
Gain or loss from assets sale
-
266.00M
-79.00M
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer